Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-15

Clinical Trial Update: SSAT061: PK of DTG and EVT/COBI in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing dolutegravir and etravirine boosted with cobicistat in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intelence (Etravirine)
  • Tivicay (dolutegravir)
  • Tybost (Cobicistat)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: COMPLETED